Gratus Capital LLC Johnson & Johnson Transaction History

Gratus Capital LLC

$2.39 Billion
Q2 2024

A detailed history of Gratus Capital LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Gratus Capital LLC holds 129,670 shares of JNJ stock, worth $18.8 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares

129,670

Previous 121,702 6.55%

Holding current value

$18.8 Million

Previous $19.3 Million 1.56%

% of portfolio

0.79%

Previous 0.91%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$144.38 - $157.78 $1.15 Million - $1.26 Million	7,968 Added 6.55%	129,670 $19 Million
Q1 2024 May 13, 2024	SELL	$155.22 - $162.74 $37,718 - $39,545	-243 Reduced 0.2%	121,702 $19.3 Million
Q4 2023 Feb 07, 2024	SELL	$145.6 - $158.88 $446,264 - $486,967	-3,065 Reduced 2.45%	121,945 $19.1 Million
Q3 2023 Oct 26, 2023	SELL	$155.75 - $174.48 $882,479 - $988,603	-5,666 Reduced 4.34%	125,010 $19.5 Million
Q2 2023 Aug 02, 2023	BUY	$154.35 - $166.11 $3.09 Million - $3.32 Million	20,013 Added 18.08%	130,676 $21.6 Million
Q1 2023 Apr 19, 2023	SELL	$151.05 - $180.26 $3.58 Million - $4.27 Million	-23,679 Reduced 17.63%	110,663 $17.2 Million
Q4 2022 Jan 27, 2023	BUY	$160.2 - $179.79 $662,266 - $743,251	4,134 Added 3.17%	134,342 $0
Q3 2022 Nov 03, 2022	BUY	$161.33 - $179.52 $1.82 Million - $2.02 Million	11,254 Added 9.46%	130,208 $21.3 Million
Q2 2022 Jul 29, 2022	BUY	$168.19 - $186.01 $823,626 - $910,890	4,897 Added 4.29%	118,954 $21.1 Million
Q1 2022 Apr 29, 2022	BUY	$158.14 - $179.59 $393,926 - $447,358	2,491 Added 2.23%	114,057 $20.2 Million
Q4 2021 Jan 31, 2022	BUY	$155.93 - $173.01 $1.24 Million - $1.38 Million	7,977 Added 7.7%	111,566 $19.1 Million
Q3 2021 Nov 05, 2021	BUY	$161.5 - $179.47 $666,672 - $740,852	4,128 Added 4.15%	103,589 $16.7 Million
Q2 2021 Aug 10, 2021	BUY	$159.48 - $171.07 $1.12 Million - $1.2 Million	7,043 Added 7.62%	99,461 $16.4 Million
Q1 2021 May 04, 2021	BUY	$153.07 - $170.48 $242,156 - $269,699	1,582 Added 1.74%	92,418 $15.2 Million
Q4 2020 Feb 03, 2021	BUY	$137.11 - $157.38 $645,376 - $740,787	4,707 Added 5.47%	90,836 $14.3 Million
Q3 2020 Oct 30, 2020	BUY	$140.38 - $153.83 $291,288 - $319,197	2,075 Added 2.47%	86,129 $12.8 Million
Q2 2020 Aug 11, 2020	SELL	$128.81 - $155.51 $101,888 - $123,008	-791 Reduced 0.93%	84,054 $11.8 Million
Q1 2020 May 01, 2020	BUY	$111.14 - $153.99 $485,570 - $672,782	4,369 Added 5.43%	84,845 $11.1 Million
Q4 2019 Feb 07, 2020	SELL	$127.5 - $146.44 $72,165 - $82,885	-566 Reduced 0.7%	80,476 $11.7 Million
Q3 2019 Oct 30, 2019	SELL	$126.95 - $142.14 $1.17 Million - $1.31 Million	-9,209 Reduced 10.2%	81,042 $10.5 Million
Q2 2019 Aug 07, 2019	BUY	$131.15 - $144.24 $268,595 - $295,403	2,048 Added 2.32%	90,251 $12.6 Million
Q1 2019 May 14, 2019	BUY	$125.72 - $139.79 $387,720 - $431,112	3,084 Added 3.62%	88,203 $12.3 Million
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $601,670 - $724,120	-4,898 Reduced 5.44%	85,119 $11 Million
Q4 2018 Feb 13, 2019	BUY	$122.84 - $147.84 $754,114 - $907,589	6,139 Added 7.32%	90,017 $11.6 Million
Q3 2018 Nov 09, 2018	BUY	$121.58 - $142.88 $228,691 - $268,757	1,881 Added 2.29%	83,878 $11.6 Million
Q2 2018 Aug 13, 2018	BUY	$119.4 - $131.76 $9,074 - $10,013	76 Added 0.09%	81,997 $9.95 Million
Q1 2018 May 10, 2018	SELL	$125.1 - $148.14 $1.22 Million - $1.45 Million	-9,756 Reduced 10.64%	81,921 $10.5 Million
Q4 2017 Feb 07, 2018	BUY	$131.22 - $143.62 $837,052 - $916,151	6,379 Added 7.48%	91,677 $12.8 Million
Q3 2017 Nov 09, 2017	BUY	$129.47 - $135.38 $267,743 - $279,965	2,068 Added 2.48%	85,298 $11.1 Million
Q2 2017 Aug 08, 2017	BUY	N/A	83,230	83,230 $11 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $380B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gratus Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gratus Capital LLC with notifications on news.

Account

Gratus Capital LLC Johnson & Johnson Transaction History